Hudson Bay Capital Management LP Acadia Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

A detailed history of Hudson Bay Capital Management LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 375,000 shares of ACAD stock, worth $6.44 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

375,000

Previous 387,500 3.23%

Holding current value

$6.44 Million

Previous $6.3 Million 8.34%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $189,250 - $239,250	-12,500 Reduced 3.23%	375,000 $5.77 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $2.38 Million - $2.99 Million	162,500 Added 72.22%	387,500 $6.3 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $4 Million - $6.94 Million	225,000 New	225,000 $4.16 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $2.45 Million - $3.14 Million	-150,000 Reduced 75.0%	50,000 $941,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $355,000 - $465,750	25,000 Added 14.29%	200,000 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $1.48 Million - $1.92 Million	-105,000 Reduced 37.5%	175,000 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $3.38 Million - $7.08 Million	260,000 Added 1300.0%	280,000 $3.95 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $523,500 - $687,500	-25,000 Reduced 55.56%	20,000 $484,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $3.04 Million - $4.9 Million	-181,000 Reduced 80.09%	45,000 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $2.62 Million - $4.11 Million	166,000 Added 276.67%	226,000 $3.75 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $582,000 - $822,600	30,000 Added 100.0%	60,000 $1.46 Million
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $750,600 - $1.65 Million	30,000 New	30,000 $774,000
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $1.23 Million - $1.7 Million	-30,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $1.09 Million - $1.71 Million	30,000 New	30,000 $1.24 Million
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $333,300 - $660,150	-15,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $358,000 - $573,000	-25,000 Reduced 62.5%	15,000 $243,000
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $602,800 - $893,600	40,000 New	40,000 $611,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Acadia Pharmaceuticals Inc Transaction History